About Orbactiv
- Headquarter United States
- SectorsHealthcare
- Website orbactiv.com
- Acquired by Menarini (Oct 2018)
- Legal Name Melinta Therapeutics, Inc
- Investors
- Acquired byMenarini
(Oct 2018)
Investors in Orbactiv
Orbactiv has secured backing from 1 investor. Prominent investors backing the company include Menarini Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Menarini Group is engaged in pharmaceutical and healthcare solutions. | – | menarini.com | Florence, Italy |
Investor details for Orbactiv
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Orbactiv
2 dated milestones of Orbactiv across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Orbactiv is founded.
- Exit Acquired by Menarini.
Web traffic of Orbactiv
The website of Orbactiv (orbactiv.com) receives about 2K visits a month.
- Monthly visits2K
▲ 60.1% vs previous month
Similar companies to Orbactiv
10 companies that operate in the same segment as Orbactiv (Pharmacy & Healthcare Retail Systems), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | – | – | |
Online community and B2B platform for pharmacy professionals is operated. | 2012 | Singapore, Singapore | USD 10 M | – | – | |
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 | |
Offers a B2B managed marketplace for pharmacies | 2019 | Bengaluru, Karnataka, India | USD 20.02 M | USD 20.23 M | 218 | |
Digital healthcare tools are offered for pharmacies and clinics management. | 2012 | Mumbai, Maharashtra, India | USD 929.11 M | USD 805.55 M | 221 | |
Prescription drugs refill management solutions | 2015 | San Francisco, California, United States | USD 105.54 M | – | 99 | |
On-demand prescription delivery is facilitated for patients through pharmacists' workflows. | 2016 | Jacksonville, United States | USD 30.64 M | – | 95 | |
Medication management systems are supplied to healthcare providers and pharmacies. | 1968 | Columbus, Ohio, United States | USD 8.3 M | – | – | |
Provider of supply chain management platform | 2009 | Columbus, Ohio, United States | USD 5.76 M | – | 55 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Orbactiv
Orbactiv was founded in 2014.
Orbactiv is headquartered in United States.
Developer of a single-dose antibiotic for bacterial skin infections. This antibiotic offers an alternative treatment for acute bacterial skin and skin structure infections caused by specific gram-positive microorganisms. It provides a single-dose option compared to multiple-dose regimens, and the company offers support programs for insurance verification, billing, and patient assistance. The product has three mechanisms of action and is indicated for adult patients. Important safety information includes potential interactions with anticoagulants and the need for monitoring of certain coagulation tests. Adverse reactions are documented in the full prescribing information.
Orbactiv has 1 investor. Key investors include Menarini Group.
Orbactiv operates through Melinta Therapeutics, Inc.
Yes. Orbactiv was acquired by Menarini in October 2018.